Used primarily in pharmaceutical research as a chiral building block for the synthesis of neuroactive compounds. It serves as a key intermediate in developing drugs that target central nervous system disorders, including depression and neuropathic pain. Its structural similarity to nicotinic receptor ligands makes it valuable in designing molecules that modulate neurotransmitter activity. Also employed in the development of novel agonists and antagonists for receptor binding studies.